Several ASX companies are conducting clinical trials, and this has become a valuable sector and an asset to the Australian ...

Sarepta's Elevidys approval, revenue growth projections, and competitive position make it a strong investment in DMD ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...

“We didn't see evidence of that in our study, but it's definitely something you would want to keep an eye out for.” Denali ...

In the trial, doses ranging from 0.5mg to 0.9mg of ALG-055009 led to notable median relative reductions in liver fat.

Two patients dosed; several additional patients screened for enrollmentTrial to evaluate safety and tolerability of TTX-MC138 in patients with metastatic cancerTTX-MC138 is an antisense ...

ASX health stocks have fallen this week but Morgans analyst Scott Power is more optimistic after the Fed cut the cash rate by ...

Manuscript Highlights Therapeutic Potential of BP1003 in Variety of CancersMarks Company’s Twenty-Second Peer-Reviewed Publication in Support of ...

Increased funding and new public health policies for sickle cell research are needed to ease the burden on low-income nations ...

Novo Nordisk isn’t done with the RNA deals, this time penning a $530 million biobucks deal to work with Korro Bio on two ...

Activation of macrophage TLR4 by bacterial endotoxins is important for the progression of sepsis, but the underlying ...